EF
IRD

Empowered Funds’s Opus Genetics IRD Stock Holding History

Empowered Funds’s Portfolio IRD Stock Details IRD Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$191K Hold
42,065
– – ﹤0.01% 2027
2025
Q4 		$84.6K Hold
42,065
– – ﹤0.01% 980
2025
Q3 		$69.4K Hold
42,065
– – ﹤0.01% 1800
2025
Q2 		$39.6K Hold
42,065
– – ﹤0.01% 1739
2025
Q1 		$41.3K Hold
42,065
– – ﹤0.01% 1607
2024
Q4 		$50.1K Buy
42,065
+750
+2% +$861 ﹤0.01% 1614
2024
Q3 		$54.1K Buy
41,315
+2,010
+5% +$3.1K ﹤0.01% 1384
2024
Q2 		$60.1K Buy
39,305
+2,700
+7% +$4.67K ﹤0.01% 1357
2024
Q1 		$73.6K Buy
+36,605
New +$92.8K ﹤0.01% 1351

Other funds holding IRD

CP
Caligan Partners New York $1.5B AUM 518.95% 1-Year Est. Return
Adage Capital Partners
Adage Capital Partners Boston, Massachusetts $64.8B AUM 42.7% 1-Year Est. Return
BCM
BIOS Capital Management Fort Worth, Texas $52.9M AUM 30.51% 1-Year Est. Return
Balyasny Asset Management
Balyasny Asset Management Chicago, Illinois $77.1B AUM 42.89% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
Marshall Wace
Marshall Wace London, United Kingdom $100B AUM 35.1% 1-Year Est. Return
BCM
Boxer Capital Management San Diego, California $762M AUM 1,125.36% 1-Year Est. Return
ACM
ADAR1 Capital Management Austin, Texas $1.7B AUM 340.85% 1-Year Est. Return
PA
Perceptive Advisors New York $5.12B AUM 314.02% 1-Year Est. Return

Empowered Funds's IRD Position: Q1 2026 in Review

Empowered Funds held its Opus Genetics (IRD) position steady in Q1 2026 at 42,065 shares worth $191K. The position accounts for ﹤0.01% of the portfolio, ranked #2027.

Empowered Funds first reported a position in IRD in Q1 2024 and has held it in 9 quarters since. 79 funds tracked by Wall St. Rank hold IRD as of Q1 2026.

  • Empowered Funds held 42,065 shares of Opus Genetics worth $191K as of Q1 2026.
  • Empowered Funds left its Opus Genetics share count unchanged in Q1 2026.
  • Opus Genetics made up ﹤0.01% of Empowered Funds's portfolio in Q1 2026, its #2027 holding.
  • Empowered Funds first reported a position in Opus Genetics in Q1 2024 and has held it in 9 quarters since.
  • 79 funds tracked by Wall St. Rank held Opus Genetics as of Q1 2026.

Based on Empowered Funds's 13F filing for Q1 2026, filed 15 May 2026.